Package 0003-4522-11

{"route": ["INTRAVENOUS"], "spl_id": "8441efc2-338a-4d1d-8fa1-9b9863a49ffd", "openfda": {"nui": ["N0000192338", "N0000192337", "M0001357"], "upc": ["0300032291118"], "unii": ["1351PE5UGS"], "rxcui": ["1726110", "1726115", "1726117", "1726119"], "spl_set_id": ["80686b7e-f6f4-4154-b5c0-c846425e2d91"], "pharm_class_cs": ["Antibodies, Monoclonal [CS]"], "pharm_class_epc": ["SLAMF7-directed Immunostimulatory Antibody [EPC]"], "pharm_class_moa": ["SLAMF7-directed Antibody Interactions [MoA]"], "manufacturer_name": ["E.R. Squibb & Sons, L.L.C."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-USE in 1 CARTON (0003-4522-11)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-USE", "package_ndc": "0003-4522-11", "marketing_start_date": "20151130"}], "brand_name": "EMPLICITI", "product_id": "0003-4522_8441efc2-338a-4d1d-8fa1-9b9863a49ffd", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Antibodies", "Monoclonal [CS]", "SLAMF7-directed Antibody Interactions [MoA]", "SLAMF7-directed Immunostimulatory Antibody [EPC]"], "product_ndc": "0003-4522", "generic_name": "elotuzumab", "labeler_name": "E.R. Squibb & Sons, L.L.C.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EMPLICITI", "active_ingredients": [{"name": "ELOTUZUMAB", "strength": "400 mg/1"}], "application_number": "BLA761035", "marketing_category": "BLA", "marketing_start_date": "20151130", "listing_expiration_date": "20261231"}